Midazolam pretreatment does not ameliorate myoglobinemia or the clinical side effects of succinylcholine.

Author: FisherE, FisherQ A, MatjaskoM J

Paper Details 
Original Abstract of the Article :
STUDY OBJECTIVE: To determine whether the levels of serum myoglobin and the occurrence of fasciculations and postoperative symptoms following a single dose of succinylcholine are modified by the prior administration of midazolam. DESIGN: Randomized, double-blind, placebo-controlled study. SETTING:...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0952-8180(93)90107-p

データ提供:米国国立医学図書館(NLM)

Succinylcholine and Myoglobinemia: A Desert of Unexpected Findings

Succinylcholine is a muscle relaxant commonly used in anesthesia, but its use can be associated with myoglobinemia, a condition where myoglobin, a protein found in muscle tissue, is released into the bloodstream. This study investigated whether pretreatment with midazolam, a sedative, could mitigate the risk of myoglobinemia and other side effects associated with succinylcholine. The researchers conducted a randomized, double-blind, placebo-controlled study to assess the effects of midazolam pretreatment.

Midazolam: No Oasis in the Desert of Myoglobinemia

The study's findings were unexpected, revealing that midazolam had no significant effect on myoglobin levels or postoperative symptoms following succinylcholine administration. This research underscores the complexity of the interaction between medications, highlighting the importance of further investigation to identify effective strategies for managing myoglobinemia and other side effects associated with succinylcholine. It's like venturing into an unknown desert, where the expected oasis is absent, prompting further exploration for solutions.

Managing Anesthesia Risks: A Careful Approach

Anesthesia procedures require careful consideration of potential risks and side effects. This research highlights the importance of ongoing research to better understand the mechanisms and management of myoglobinemia and other complications associated with anesthesia. It's a reminder that even in the seemingly familiar territory of medical procedures, there are still uncharted deserts to explore, requiring vigilance and ongoing innovation.

Dr.Camel's Conclusion

This study presents a fascinating and unexpected journey through the desert of myoglobinemia. While midazolam did not offer a solution for myoglobinemia, the research underscores the need for continued exploration to optimize anesthesia practices and minimize potential complications.

Date :
  1. Date Completed 1993-12-09
  2. Date Revised 2019-09-14
Further Info :

Pubmed ID

8217179

DOI: Digital Object Identifier

10.1016/0952-8180(93)90107-p

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.